MeiraGTx will receive an upfront payment of $75 million and will be eligible to receive over $400 million in total milestone ...

MeiraGTx shares rise after signing a $475 million deal with Eli Lilly for a gene therapy program restoring vision in children ...

MeiraGTx (MGTX) stock climbs as the company partners with Eli Lilly (LLY) to develop and sell gene therapies for eye diseases ...

The latest announcement is out from Meiragtx Holdings ( (MGTX) ).

LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic ...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F ...

This put 7.11% of the company's publicly available shares short. Short interest in MeiraGTx Hldgs Corp (XNAS:MGTX) decreased during the last reporting period, falling from 280.30M to 275.20M. This put ...

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish catastrophic capital loss on anyone. Imagine if you held MeiraGTx Holdings plc ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Amgen Inc (Symbol: AMGN), where a total of 23,460 contracts have traded so far, ...

MeiraGTx Holdings’ MGTX clinical bridging study of its gene therapy candidate, AAV-GAD, for treating Parkinson’s disease (PD) met its primary study objective of safety and tolerability. The stock ...

MeiraGTx Holdings plc (MGTX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

MeiraGTx Holdings PLC Annual stock financials by MarketWatch. View the latest MGTX financial statements, income statements and financial ratios.